Bulevirtide vs Navepegritide

A side-by-side comparison from PeptideSciences101, the open peptide reference.

Overview

Bulevirtide is primarily a antiviral peptide, while Navepegritide is used for bone & joint.

This page compares Bulevirtide and Navepegritide across their primary use, typical dosing, reported benefits and side effects, and U.S. regulatory status. For the full monograph on either compound — mechanism of action, clinical research, and references — follow the article links.

Side-by-side comparison

BulevirtideNavepegritide
CategoryAntiviralBone & Joint
Regulatory status (US)FDA approvedFDA approved
Typical dosage
Frequency
Reported benefits
Reported side effects

Key differences

Primary use. Bulevirtide is categorised under Antiviral, while Navepegritide falls under Bone & Joint. Their differing categories mean they are usually chosen for different goals rather than as direct substitutes.

Regulatory status. Bulevirtide: FDA-approved. Navepegritide: FDA-approved.

Can you stack them?

Some protocols combine peptides, but stacking Bulevirtide and Navepegritide has not been validated for safety or efficacy in controlled trials. Combining compounds can change their effects and risks. Nothing here is medical advice — consult a qualified healthcare provider before starting or combining any protocol.

Frequently asked questions

What is the difference between Bulevirtide and Navepegritide?
Bulevirtide is primarily a antiviral peptide, while Navepegritide is used for bone & joint. Bulevirtide is FDA-approved for one or more indications, whereas Navepegritide is FDA-approved for one or more indications.
What is Bulevirtide used for?
First/only FDA-approved treatment for chronic hepatitis delta virus (HDV). FDA accelerated approval May 22, 2026. Brand: Hepcludex (Gilead).
What is Navepegritide used for?
PEGylated CNP analog for achondroplasia. FDA approved February 27, 2026.
Can you take Bulevirtide and Navepegritide together?
Some users combine peptides within a single protocol, but stacking Bulevirtide and Navepegritide has not been established as safe or effective in controlled trials. Neither this comparison nor PeptideSciences101 is medical advice — consult a qualified healthcare provider before combining any compounds.
Is Bulevirtide or Navepegritide FDA-approved?
Bulevirtide is FDA-approved for one or more indications. Navepegritide is FDA-approved for one or more indications.

Read the full articles

  • Bulevirtide — full monograph: mechanism, research, dosing & references
  • Navepegritide — full monograph: mechanism, research, dosing & references

Bulevirtide compared across categories

← All peptide comparisons